about camurus news products technologies partnering contact Delivering better treatments Camurus is a research focused pharmaceutical company with a firm commitment to the development and commercialization of innovative specialty medicines that provide patients, suffering from serious disease, ... Read more › news and events 2015-03-29 00:00:00 Solasia acquires exclusive license and distribution rights from Camurus for Read more › 2015-10-13(-15) CPhI Worldwide Read more › products episil® Oral mucositis pain episil® oral liquid is a unique local treatment of pain in the oral cavity resulting from inflammation and ulcers in the oral cavity. It has b... Read more › technologies FluidCrystal® Injection depot Camurus' FluidCrystal® injection depot delivers therapeutic levels of drug substance over extended periods - tunable from days to months - fro... Read more › partnering Tailored partnerships To exploit the full potential of our product development and proprietary drug delivery technologies and innovative products, Camurus is forming developmen... Read more › Innovative nanoscale therapeutics © 2014 Camurus AB home about camurus news products technologies partnering career press contact This website contains information on products which is targeted to a wide audiences and could contain details or information other wise not accessible or valid in your country. Please be aware that we do not take any responibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your region. legal notice privacy policy sitemap Login